|
Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop |
Medicines for Europe |
Wed, 10/30/2019 |
Health & Consumers |
|
Report identifies 9 key ingredients to improve access to medicines in the hospital setting |
Medicines for Europe |
Tue, 10/08/2019 |
Health & Consumers |
|
EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement |
Medicines for Europe |
Mon, 09/30/2019 |
Health & Consumers |
|
Immediately calls on new President of EU Commission to prioritise Healthcare |
Medicines for Europe |
Wed, 09/25/2019 |
Health & Consumers, InfoSociety |
|
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector |
Medicines for Europe |
Tue, 09/24/2019 |
Health & Consumers |
|
Ready to drive access to medicines |
Medicines for Europe |
Wed, 07/24/2019 |
Health & Consumers |
|
‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access |
Medicines for Europe |
Wed, 04/03/2019 |
Health & Consumers |
|
New safeguards for patient safety as Falsified Medicines Directive comes into force |
Medicines for Europe |
Mon, 02/11/2019 |
Health & Consumers |
|
SPC manufacturing waiver cannot be derailed by foreign vested interests |
Medicines for Europe |
Thu, 02/07/2019 |
Health & Consumers |
|
Efficient use of pharmacovigilance data essential for patient safety |
Medicines for Europe |
Wed, 01/30/2019 |
Health & Consumers |
|
Competition policy essential for access to medicines |
Medicines for Europe |
Tue, 01/29/2019 |
Health & Consumers |
|
Crucial European Parliament vote vastly improves SPC manufacturing waiver |
Medicines for Europe |
Thu, 01/24/2019 |
Health & Consumers |
|
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! |
Medicines for Europe |
Tue, 12/04/2018 |
Health & Consumers |
|
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. |
Medicines for Europe |
Fri, 11/30/2018 |
Health & Consumers |
|
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). |
Medicines for Europe |
Wed, 11/28/2018 |
Health & Consumers |
|
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines |
Medicines for Europe |
Mon, 11/26/2018 |
Health & Consumers |
|
Value added medicines: Continuous innovation crucial to improve healthcare across Europe |
Medicines for Europe |
Wed, 11/21/2018 |
Health & Consumers |
|
Driving local excellence, delivering European results |
Medicines for Europe |
Tue, 11/06/2018 |
Health & Consumers |
|
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver |
Medicines for Europe |
Mon, 10/22/2018 |
Health & Consumers |
|
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers |
Medicines for Europe |
Fri, 10/12/2018 |
Health & Consumers |
|
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court |
Medicines for Europe |
Thu, 09/20/2018 |
Health & Consumers |
|
SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform |
Medicines for Europe |
Tue, 09/18/2018 |
Health & Consumers |
|
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses |
Medicines for Europe |
Tue, 06/26/2018 |
Health & Consumers |
|
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community |
Medicines for Europe |
Fri, 06/22/2018 |
Health & Consumers |
|
Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest |
Medicines for Europe |
Thu, 06/14/2018 |
Health & Consumers |
|
Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe |
Medicines for Europe |
Mon, 05/28/2018 |
Health & Consumers, Social Europe & Jobs |
|
EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability |
Medicines for Europe |
Thu, 05/24/2018 |
Health & Consumers |
|
Biosimilar Medicines: essential for sustainable access to medicines |
Medicines for Europe |
Fri, 04/27/2018 |
Health & Consumers |
|
SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14th Legal Affairs Conference |
Medicines for Europe |
Wed, 04/25/2018 |
Health & Consumers |
|
Supply chain commitment to tackling problem of medicine shortages |
Medicines for Europe |
Fri, 03/02/2018 |
Health & Consumers |
